Does RUCAPARIB CAMSYLATE Cause Infection? 66 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Infection have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.8% of all adverse event reports for RUCAPARIB CAMSYLATE.
66
Reports of Infection with RUCAPARIB CAMSYLATE
0.8%
of all RUCAPARIB CAMSYLATE reports
4
Deaths
21
Hospitalizations
How Dangerous Is Infection From RUCAPARIB CAMSYLATE?
Of the 66 reports, 4 (6.1%) resulted in death, 21 (31.8%) required hospitalization.
Is Infection Listed in the Official Label?
Yes, Infection is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Infection Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE